Real-time analysis of shear-dependent thrombus formation and its blockade by inhibitors of von Willebrand factor binding to platelets

Autor: B R, Alevriadou, J L, Moake, N A, Turner, Z M, Ruggeri, B J, Folie, M D, Phillips, A B, Schreiber, M E, Hrinda, L V, McIntire

Publikováno v: Blood. 81:1263-1276

Two likely mechanisms for the initiation of arterial platelet thrombus formation under conditions of elevated fluid shear stresses are: (1) excessive adhesion and aggregation of platelets from rapidly flowing blood onto the exposed sub-endothelium of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93e9eace477c6a2d9cd83bffeba956e4
https://doi.org/10.1182/blood.v81.5.1263.bloodjournal8151263

Adenovirus-mediated expression of tissue plasminogen activator does not alter endothelial cell proliferation and invasion

Autor: D K, Zablocki, J J, Rade, B R, Alevriadou

Publikováno v: In vitro cellulardevelopmental biology. Animal. 36(10)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::8286d985ba4280e20a494a70d0e858c5
https://pubmed.ncbi.nlm.nih.gov/11229592

MCU Upregulation Overactivates Mitophagy by Promoting VDAC1 Dimerization and Ubiquitination in the Hepatotoxicity of Cadmium.

Autor: Liu, Cong^1,2, Li, Hui-Juan³, Duan, Wei-Xia^1,2, Duan, Yu^1,2, Yu, Qin^1,2, Zhang, Tian^1,4, Sun, Ya-Pei¹, Li, Yuan-Yuan^1,2, Liu, Yong-Sheng^1,2, Xu, Shang-Cheng^1,2 xushangchengmito@163.com

Publikováno v: Advanced Science. 3/3/2023, Vol. 10 Issue 7, p1-17. 17p.

Double Braking Effects of Nanomedicine on Mitochondrial Permeability Transition Pore for Treating Idiopathic Pulmonary Fibrosis.

Autor: Lu A; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Xu Z; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Zhao Z; Department of Pharmacy, Clinical Trial Research Center, China-Japan Friendship Hospital, Beijing, 100029, China., Yan Y; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Jiang L; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Geng J; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, 100029, China., Jin H; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Wang X; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Liu X; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Zhu Y; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Shi Y; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China., Liu L; Department of Pharmacy, Clinical Trial Research Center, China-Japan Friendship Hospital, Beijing, 100029, China., Dai H; National Center for Respiratory Medicine, State Key Laboratory of Respiratory Health and Multimorbidity, National Clinical Research Center for Respiratory Diseases, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, Peking Union Medical College, Department of Pulmonary and Critical Care Medicine, Center of Respiratory Medicine, China-Japan Friendship Hospital, Beijing, 100029, China., Wang JC; Beijing Key Laboratory of Molecular Pharmaceutics and New Drug Delivery Systems, State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.; Laboratory of Innovative Formulations and Pharmaceutical Excipients, Peking University Ningbo Institute of Marine Medicine, Ningbo, 315832, China.

Publikováno v: Advanced science (Weinheim, Baden-Wurttemberg, Germany) [Adv Sci (Weinh)] 2024 Oct 30, pp. e2405406. Date of Electronic Publication: 2024 Oct 30.

Revealing the Adverse Effects of Trace Amount Broad‐Spectrum Antimicrobial: a Direct and Sensitive Visualization Method Based on Carbon Nanoprobe.

Autor: Geng, Xin, Guo, Yifei, Wang, Ying, Zhai, Yongxin, Xu, Beining, Qu, Lingbo, Li, Zhaohui

Publikováno v: Advanced Functional Materials; 10/21/2022, Vol. 32 Issue 43, p1-8, 8p